GOOD REVIEW PRACTICES INITIATIVE SEEKS CONSISTENCY IN FDA/INDUSTRY INTERACTIONS, CDER's WOODCOCK SAYS; CENTER-WIDE FORMULATION GROUP BEING CONSIDERED
Executive Summary
FDA's Good Review Practices agency-wide initiative contemplates the development of a guidance to standardize the manner in which FDA reviewers and other personnel interact with industry, Center for Drug Evaluation & Research Director Janet Woodcock said in a June 28 briefing with trade press. Woodcock assumed the center director position at the end of May.